|
Animal Health
(NP #103)
|
|
Countermeasures to Control and Eradicate Foreign Animal Diseases of Swine
(In-House Appropriated)
|
|
Ecology of Vesicular Stomatitis Virus (VSV) in North America
(In-House Appropriated)
|
|
Intervention Strategies to Support the Global Control and Eradication of Foot-and-Mouth Disease Virus (FMDV)
(In-House Appropriated)
|
|
Development of Diagnostic Tests for FMDV Sub-Saharan Strains
(Cooperative Agreement)
|
|
Foot-and-mouth disease surveillance in Vietnam
(Cooperative Agreement)
|
|
Foot-And-Mouth Disease Surveillance, Diagnostics and Antigenic Matching Research in Uganda
(Cooperative Agreement)
|
|
Foot-And-Mouth Disease Virus Diagnostic Test Development in Uganda
(Cooperative Agreement)
|
|
A DIVA Compatible Vaccine Against Classical Swine Fever (CSF) Made in the USA
(Interagency Reimbursable Agreement)
|
|
Alternative Approaches for the Development of an Experimental African Swine Fever Virus (ASFV) Vaccine
(Interagency Reimbursable Agreement)
|
|
Development of a Live Attenuated African Swine Fever Virus Vaccine With DIVA Capability
(Interagency Reimbursable Agreement)
|
|
Development of Deoptimized Live Attenuated Foot-Mouth-Disease Virus Vaccine Candidates
(Interagency Reimbursable Agreement)
|
|
Exploration Into a Stable Cell Line Capable to Support African Swine Fever Growth
(Interagency Reimbursable Agreement)
|
|
Foot-and-Mouth Disease Virus Ecology and Surviellance in Vietnam; Exploiting Asymptomatic Carriers to Monitor Field Strains
(Interagency Reimbursable Agreement)
|
|
Foot-and-Mouth-Disease Virus Vaccines with Broad Breadth of Protection Against Diverse Virus Strains
(Interagency Reimbursable Agreement)
|
|
Leveraging Clincal Studies at Plum Island Animal Disease Center to Improve Paramterization of Foreign Animal Disease Models
(Interagency Reimbursable Agreement)
|
|
Susceptibility of Pigs to FMD Infection via Natural Ingestion: Establishing Minimum Oral Infectious Dose and Evaluating...Mitigates
(Interagency Reimbursable Agreement)
|
|
Using Novel Experimental Data to Enhance Modeling of Foreign Animal Disease Threats to Livestock Within the US Homeland.
(Interagency Reimbursable Agreement)
|
|
Development of a Next-Generation African Swine Fever Vaccine using Bioinformatic Analysis of Circulating Strains in Uganda
(Non-Funded Cooperative Agreement)
|
|
Development of novel and/or improved vaccines strains of Classical Swine Fever Virus (CSFV) and African Swine Fever Virus (ASFV)
(Non-Funded Cooperative Agreement)
|
|
Foreign Animal Disease Research and Development Activities to Address High Priority Transboundary Animal Diseases
(Non-Funded Cooperative Agreement)
|
|
Longitudinal Data and Modeling to Support the Global Control and Eradication of Foot-and-Mouth Disease Virus
(Non-Funded Cooperative Agreement)
|
|
Use of Monoclonal Antibodies to Study Interaction Between Foot-and-Mouth Disease Virus and Host Proteins During Infection
(Non-Funded Cooperative Agreement)
|
|
Construct and Test Recombinant Adenoviruses Vectoring African Swine Fever Virus Genes in Inducing Immune Protection in Pigs.
(Reimbursable Cooperative Agreement)
|
|
Susceptibility of Pigs to FMD Infection via Natural Ingestion: Establishing Minimum Oral Infectious Dose and Evaluating...Mitigates
(Reimbursable Cooperative Agreement)
|
|
Susceptiblity of Pigs to FMD Infection via Natural Ingestion: Establishing Minimum Oral Infectious Dose and Evaluating...Mitigants
(Reimbursable Cooperative Agreement)
|
|
Analysis of the Interaction between Classical Swine Fever Virus Proteins and the Host Cell Membranes
(Non-Assistance Cooperative Agreement)
|
|
Analysis of the Interaction Between Virus Proteins and Membrane Structures in Cells Infected with Classical Swine Fever Virus (CSFV)
(Non-Assistance Cooperative Agreement)
|
|
Ankara Virus Vector Assessment: Development of Viral-Vectored Vaccines for African Swine Fever Virus
(Non-Assistance Cooperative Agreement)
|
|
Development of Novel Countermeasures Against Swine Diseases
(Non-Assistance Cooperative Agreement)
|
|
Development of Recombinant African Swine Fever Viruses: Attenuated Viruses Containing Multiple Deletions for Use as Vaccine Candidates
(Non-Assistance Cooperative Agreement)
|
|
Epidemiological Analysis of FMD Virus in Uganda
(Non-Assistance Cooperative Agreement)
|
|
Genetic Characterization and Diagnostic Detection of Emerging Vesicular Stomatitis Virus in North America
(Non-Assistance Cooperative Agreement)
|
|
Improved Immunogenic Vectors for Classical Swine Fever and Porcine Reproduction and Respository Syndrom Viruses
(Non-Assistance Cooperative Agreement)
|
|
Longitudinal Study of FMD Vaccinated and Unvaccinated Cattle in Cameroon
(Non-Assistance Cooperative Agreement)
|
|
Preliminary Study for the Reversion to Virulence Study of FMDV-LL3B3D-A24 Cruzeiro in Swine
(Non-Assistance Cooperative Agreement)
|
|
Quantitative Analyses of Foot-and-Mouth Disease in Endemic Regions of Asia and Africa
(Non-Assistance Cooperative Agreement)
|
|
Research Supporting Workforce Development for the National Bio-Agro Defense Facility: Development of CSF Subunit Vaccines
(Non-Assistance Cooperative Agreement)
|
|
Research Supporting Workforce Development for the National Bio-Agro Defense Facility: Development of Novel Foot-and-Mouth Disease Virus...Candidates
(Non-Assistance Cooperative Agreement)
|
|
Research Supporting Workforce Development for the National Bio-Agro Defense Facility: Virus-Host Interactions of Vesicular Stomatitis Virus
(Non-Assistance Cooperative Agreement)
|
|
Role of the Local and Systemic Immunity in the Protection Against Virulent FMDV Challenge by the Oronasal Route in Cattle
(Non-Assistance Cooperative Agreement)
|
|
The Impact of Acute Subclinical Foot-and-Mouth Disease Virus in Kenyan Cattle
(Non-Assistance Cooperative Agreement)
|
|
Understanding Cross-Reactive Responses Between Heterologous Foot-and-Mouth Disease Virus Strains in the Bovine Model
(Non-Assistance Cooperative Agreement)
|
|
Understanding Pathogenesis and Epidemiology for Controlling Foreign Animal Diseases
(Non-Assistance Cooperative Agreement)
|
|
Development of Recombinant Porcine Cytomegalovirus (pCMV)- vaccine vector(s) using Korean pCMV field isolates
(Trust Fund Cooperative Agreement)
|
